- Price
- $29.36
- Day
- +7.90%
- Mkt Cap
- $3.65B
- 52W Range
- $6.21 – $34.39
- Volume
- 1.80M
- Beta
- 1.15
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Shares of Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report) have received an average rating of "Moderate Buy" from the sixteen research firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and thirteen have given a buy
Read full article
Medical sector earnings are off to a strong start, and four biotech companies are positioned to potentially beat estimates in upcoming quarterly results.
Read full article
The average of price targets set by Wall Street analysts indicates a potential upside of 49.5% in Tango Therapeutics (TNGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read full article
Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report)'s share price shot up 6.1% on Friday. The stock traded as high as $29.25 and last traded at $29.3360. 316,615 shares changed hands during trading, a decline of 91% from the average daily volume of 3,701,445 shares. The stock had previously closed at $27.64. Analyst Upgrades
Read full article